发明名称 CLAUDINS' UNDEREXPRESSION AS MARKERS OF TUMOR METASTASIS
摘要 A method for treating cancer in a mammal comprised of administering a therapeutically effective amount of an agent that induces the expression of one or more claudins within a cancerous cell. Preferably the claudin is claudin-3, claudin-4 aor claudin-9. In a preferred method, a nucleic acid that encodes a claudin is administered to the mammal under conditions wherein the nucleic acid is transfected into the cancerous cell and the claudin is produced in the cell. Also disclosed is a method for diagnosing cancer comprising determining the presence of a claudin 3, 4 or 9 in a cell that normally expresses the protein. If the cell does not express the claudin, then it is cancerous.
申请公布号 WO2004098647(A3) 申请公布日期 2005.03.03
申请号 WO2004US13436 申请日期 2004.04.30
申请人 NASTECH PHARMACEUTICAL COMPANY INC.;QUAY, STEVEN, C.;CUI, KUNYUAN 发明人 QUAY, STEVEN, C.;CUI, KUNYUAN
分类号 A61K;A61K48/00;C12N15/86;C12Q1/68;G01N33/574 主分类号 A61K
代理机构 代理人
主权项
地址